Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial

…, R Sarkar, K Thomas, V Jeebun, A Ashish… - Medrxiv, 2021 - medrxiv.org
Background Tocilizumab is a monoclonal antibody that binds to the receptor for interleukin (IL)-6,
reducing inflammation, and is commonly used to treat rheumatoid arthritis. We …

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled …

…, MJ Cates, M Mandizha, A Ashish… - The Lancet …, 2023 - thelancet.com
Background Interstitial lung disease is a known complication of rheumatoid arthritis, with a
lifetime risk of developing the disease in any individual of 7·7%. We aimed to assess the safety…

CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation

A Ashish, A Unsworth, J Martindale… - BMJ open …, 2020 - bmjopenrespres.bmj.com
Objective To evaluate the role of continuous positive air pressure (CPAP) in the management
of respiratory failure associated with COVID-19 infection. Early clinical management with …

[HTML][HTML] Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis

A Ashish, S Paterson, E Mowat, JL Fothergill… - Journal of Cystic …, 2013 - Elsevier
Background Populations of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa
undergo extensive diversification in the cystic fibrosis (CF) lung during long-term chronic …

[HTML][HTML] Increasing resistance of the Liverpool epidemic strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—a cause for concern?

A Ashish, M Shaw, C Winstanley, MJ Ledson… - Journal of cystic …, 2012 - Elsevier
BACKGROUND: Transmissible Pseudomonas aeruginosa (Psa) strains such as the Liverpool
Epidemic Strain (LES) are now widespread throughout UK CF clinics: their susceptibility to …

Halting the spread of epidemic Pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study

A Ashish, M Shaw, C Winstanley… - JRSM short …, 2013 - journals.sagepub.com
Objectives To assess if cohort segregation policies are effective in preventing cross-infection
in cystic fibrosis (CF) clinics. Design A prospective cohort study. Setting A large adult CF …

Azithromycin in hospitalised patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

…, B Prudon, D Chadwick, A Ustianowski, A Ashish… - MedRxiv, 2020 - medrxiv.org
Background Azithromycin has been proposed as a treatment for COVID-19 on the basis of
its immunomodulatory actions. We evaluated the efficacy and safety of azithromycin in …

Health-related quality of life in Cystic Fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study

A Ashish, M Shaw, J McShane, MJ Ledson… - JRSM short …, 2012 - journals.sagepub.com
Objectives To assess the impact on health-related quality of life (HRQoL) in adult cystic
fibrosis (CF) patients of chronic infection with the Liverpool Epidemic Strain (LES) of …

[PDF][PDF] Are mRNA covid 19 vaccines safe in long covid patients? A health care workers perspective

TAK Gaber, A Ashish, A Unsworth… - British Journal of Medical …, 2021 - bjmp.org
Introduction: Long Covid patients may have concerns about the impact of mRNA vaccines
on their symptoms. Method: A short questionnaire was sent to users of a long covid service …

Prospective comparative analysis of efficacy of local debridement with or without vancomycin impregnated calcium sulphate in chronic osteomyelitis

N Jagadeesh, A Abdul, VM Shivalingappa… - Journal of Orthopaedics, 2022 - Elsevier
The primary objective of this study was to compare the efficacy of use of Vancomycin
impregnated bioabsorbable calcium sulphate (VCS) pellets along with surgical debridement to …